sehlahisoa

Lisebelisuoa tsa ho lemoha le ho lokisetsa sampole

Kankere ea Popelo

Sehlahisoa sena se sebelisetsoa ho lemoha boleng ba in vitro ba hypermethylation ea gene PCDHGB7 mefuteng ea cervical.
Ithute haholoanyane >>
Kankere ea Endometrial

Sehlahisoa sena se sebelisetsoa ho lemoha boleng ba in vitro ba hypermethylation ea gene PCDHGB7 mefuteng ea cervical.
Ithute haholoanyane >>
Kankere ea Urothelial

Sehlahisoa sena se sebelisetsoa ho lemoha boleng ba in vitro ba hypermethylation ea lefutso la Urothelial Carcinoma (UC) mefuteng ea urothelial.
Ithute haholoanyane >>
Kankere ea mofetše

Ho sibolloa ha mofets'e ka botlalo ke lihlahisoa tsa tlhahlobo ea plasma ctDNA methylation tse ntlafalitsoeng ke TAGMe, tse hlokang bonyane 3ml ea mali a felletseng.
Ithute haholoanyane >>

mabapi le rona

Mabapi le Epiprobe

Shanghai Epiprobe Biotechnology Co., Ltd.

seo re se etsang

Joalo ka khoebo ea theknoloji e phahameng e thehiloeng ka selemo sa 2018 ke litsebi tse phahameng tsa epigenetic, Epiprobe e shebane le tlhahlobo ea limolek'hule tsa mofets'e oa DNA methylation le indasteri e nepahetseng ea theranostic.Ka motheo o tebileng oa theknoloji, re ikemiselitse ho etella pele mehla ea lihlahisoa tse ncha ho felisa mofetše!

Ho ipapisitsoe le lipatlisiso tsa nako e telele tsa sehlopha sa Epiprobe, nts'etsopele le phetoho lefapheng la DNA methylation ka mahlale a morao-rao, a kopantsoeng le sepheo se ikhethileng sa DNA methylation ea mofets'e, re sebelisa algorithm e ikhethang e kopanyang data e kholo le mahlale a mahlale a maiketsetso. ka boikemelo ba nts'etsapele thekenoloji ea biopsy e sirelelitsoeng ka patent e ikhethileng.